The Philippine National Drug Formulary (PNDF), the main reference of PhilHealth for drug reimbursement, has been recently revised and updated by the Department of Health.

The following drugs which are newly listed in the 5th edition (latest edition) of the PNDF are now reimbursable effective May 30, 2000.

Ibuprofen		Risperidone
Codeine		Cinnarizine
Esmolol		Meclozine (Meclizine)
Gabapentin		Celecoxib
Pergolide		Etodolac
Ibuprofen		Ketoprofen
Zolpidem		Rocuronium
Fluoxetine		Mivacurium
Sertraline		Indometacin
Carbamazepine		Azathioprine
Valproate disodium		Ciclosporin
Cyclophosphamide		Zalcitabine
Hydroxychloroquine		Hemophilus Influenzae (Hib)
Meropenem		Conjugal Vaccine
Cefepime		DTP + hepatitis B vaccine
Azithromycin		DTP + Hib
Piperacillin + Tazobactam		DTP + IPV + Hib
Nalidixic Acid		Hepatitis A vaccine
Amoxicillin		Influenza Polyvalent Vaccine
Clarithromycin		Carvedilol (cardioselectiv/no ISA)
Metronidazole		Amlodipine
Minocycline		Nimodipine
Amikacin		Irbesartan
Isoniazid + Ethambutol		Losartan
Isoniazid + Rifampicin		Simvastatin
Isoniazid + Rifampicin +		Dipyridamole
	Pyrazinamide	Cetirizine
Isoniazid + Rifampicin +		Daunorubicin
	Pyrazinamide + Ethambutol	Idarubicin
Ofloxacin		Mitoxantrone
Terizodone		Tegafur + uracil
Amphotericin B		Antilymphocyte Immunoglobulin (ALG-equine)
Famciclovir		Antithymocyte Immunoglobulin (ATG-rabbit)
Lamivudine		Mycophenolate mofetil
Indinavir
Ritonavir
Saquinavir
Valaciclovir

Please be guided accordingly.

Adopted: 15 June 2000

(SGD.) ENRIQUE M. ZALAMEA
President and CEO